Use of mesna to prevent ifosfamide-induced urotoxicity

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
L L Siu, M J Moore

Abstract

The purpose of this study was to make evidence-based recommendations regarding the mode, dosage and schedule of delivery of concomitant mesna (sodium-2-mercaptoethanesulfonate) to protect against ifosfamide-induced uroepithelial toxicity. A critical review of the literature from 1966 to 1996 was undertaken on mesna administration via the intravenous, oral, or combined modality routes. Outcome measures of urinary symptoms and macrohematuria were emphasized, since these endpoints of urotoxicity are most clinically relevant. The quality of evidence obtained from published clinical research was evaluated based on guidelines developed by the Canadian Task Force on the Periodic Health Examination. Recommendations are now made according to the strength of available evidence on the proper usage of mesna as a protective agent against ifosfamide-induced urotoxicity. There is good evidence that the use of mesna significantly reduces urinary symptoms of dysuria and frequency, as well as the incidences of macrohematuria and microhematuria, when administered concurrently with any dosage of ifosfamide regardless of tumor site. Mesna, given intravenously or orally, is superior to standard prophylaxis with vigorous hydration and alkalinization ...Continue Reading

Citations

Mar 28, 2008·Surgical Endoscopy·Petros YpsilantisConstantinos Simopoulos
Feb 3, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Gerald SchwerdtMichael Gekle
Nov 14, 2003·Reproductive Toxicology·Petros YpsilantisConstantinos Simopoulos
Nov 27, 2008·Journal of Gastroenterology and Hepatology·Petros YpsilantisConstantinos Simopoulos
Nov 17, 2015·Expert Review of Anticancer Therapy·Dahlia SalmanShereen Nabhani-Gebara
May 8, 2010·Expert Opinion on Drug Metabolism & Toxicology·Bérénice GiraudAngelo Paci
Sep 11, 2008·Scandinavian Journal of Urology and Nephrology·Malcolm LawsonDavid Nicol
Mar 8, 2011·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Alain DeroussentAngelo Paci
Jan 19, 2010·The Journal of Surgical Research·Petros YpsilantisConstantinos Simopoulos
Mar 5, 2016·European Journal of Pharmacology·George LiamisMoses S Elisaf
Feb 17, 2005·European Journal of Pharmacology·Azza El-MedanyGamila El-Medany
Aug 18, 2004·The Journal of Surgical Research·Petros YpsilantisConstantinos Simopoulos
Feb 28, 2006·The Journal of Surgical Research·Petros YpsilantisConstantinos Simopoulos
May 9, 2013·Journal of Gynecologic Oncology·Xiaohuan LiDeshan Zhou
Oct 5, 2017·Therapeutic Advances in Medical Oncology·Jenna S BlelochSharon Prince
Mar 10, 2001·Clinical Pharmacokinetics·T KerbuschJ H Beijnen
Mar 22, 2019·International Urology and Nephrology·Elif Nur BarutMine Kadioglu
Jan 5, 2021·Journal of Clinical Pharmacy and Therapeutics·Shinya ShimizuAkio Suzuki
Nov 29, 2001·Rheumatic Diseases Clinics of North America·M J ReganJ H Stone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.